DE60202008D1 - Verfahren zum Auffinden von Reagenzien und Festphasenkomponenten in spezifischen Bindungsassays, frei von fortgeschrittenen Glykosylierungsendprodukten - Google Patents

Verfahren zum Auffinden von Reagenzien und Festphasenkomponenten in spezifischen Bindungsassays, frei von fortgeschrittenen Glykosylierungsendprodukten

Info

Publication number
DE60202008D1
DE60202008D1 DE60202008T DE60202008T DE60202008D1 DE 60202008 D1 DE60202008 D1 DE 60202008D1 DE 60202008 T DE60202008 T DE 60202008T DE 60202008 T DE60202008 T DE 60202008T DE 60202008 D1 DE60202008 D1 DE 60202008D1
Authority
DE
Germany
Prior art keywords
solid phase
free
reagents
finding
specific binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60202008T
Other languages
English (en)
Other versions
DE60202008T2 (de
Inventor
Dr Kientsch-Engel
Dr Gallusser
Dr Naser
Dr Lill
Dr Stahl
Theresa Kott
Josef Maier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Publication of DE60202008D1 publication Critical patent/DE60202008D1/de
Application granted granted Critical
Publication of DE60202008T2 publication Critical patent/DE60202008T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60202008T 2001-03-22 2002-03-20 Verfahren zum Auffinden von Reagenzien und Festphasenkomponenten in spezifischen Bindungsassays, frei von fortgeschrittenen Glykosylierungsendprodukten Expired - Fee Related DE60202008T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01107155 2001-03-22
EP01107155 2001-03-22

Publications (2)

Publication Number Publication Date
DE60202008D1 true DE60202008D1 (de) 2004-12-30
DE60202008T2 DE60202008T2 (de) 2005-12-01

Family

ID=8176894

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60202008T Expired - Fee Related DE60202008T2 (de) 2001-03-22 2002-03-20 Verfahren zum Auffinden von Reagenzien und Festphasenkomponenten in spezifischen Bindungsassays, frei von fortgeschrittenen Glykosylierungsendprodukten

Country Status (5)

Country Link
US (1) US20030073138A1 (de)
JP (1) JP3646097B2 (de)
AT (1) ATE283481T1 (de)
DE (1) DE60202008T2 (de)
ES (1) ES2231601T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816090B2 (en) * 2007-01-10 2010-10-19 Ortho-Clinical Diagnostics, Inc. Multiple immunochemistry assays on an element
CN102037119B (zh) * 2008-05-23 2015-06-24 Siwa有限公司 促进再生的方法、组合物及设备
WO2012047629A2 (en) 2010-09-27 2012-04-12 Siwa Corporation Selective removal of age-modified cells for treatment of ather0sclerosis
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
DE102011003944A1 (de) 2011-02-10 2012-08-16 Oxprotect Gmbh Detektion und Entfernung von missgefalteten Proteinen/Peptiden
AU2015318036B2 (en) 2014-09-19 2021-07-01 Siwa Corporation Anti-AGE antibodies for treating inflammation and auto-immune disorders
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
IL283726B2 (en) 2016-02-19 2025-05-01 Siwa Corp A preparation containing an antibody to advanced glycation end products (AGE) for use in the treatment of breast cancer
EP3443007A1 (de) 2016-04-15 2019-02-20 Siwa Corporation Anti-age-antikörper zur behandlung von neurodegenerativen erkrankungen
US11213585B2 (en) 2016-06-23 2022-01-04 Siwa Corporation Vaccines for use in treating various diseases and disorders
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
US10961321B1 (en) 2017-01-06 2021-03-30 Siwa Corporation Methods and compositions for treating pain associated with inflammation
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
BR112019021471A2 (pt) 2017-04-13 2020-05-12 Siwa Corporation Anticorpo monoclonal humanizado de produto final da glicação avançada
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318982A (en) * 1984-03-19 1994-06-07 The Rockefeller University Inhibition of the advanced glycosylation of proteins using substituted-1,2,4-triazoles
US4829009A (en) * 1986-02-21 1989-05-09 The Regents Of The University Of California Noise controlled immunoassays
US5624804A (en) * 1991-12-20 1997-04-29 The Rockefeller University Immunochemical detection of In vivo advanced glycosylation end products
US5610076A (en) * 1994-04-29 1997-03-11 Alteon Inc. Method for detecting hemoglobin advanced glycosylation endproducts
US5744318A (en) * 1994-12-30 1998-04-28 Alteon Inc. Monoclonal antibody for the detection of advanced glycosylation endproducts in biological samples
US5962245A (en) * 1995-04-05 1999-10-05 The Picower Institute For Medical Research Methods for detecting the presence of advanced glycosylation endproducts
US6380165B1 (en) * 1997-09-19 2002-04-30 The Picower Institute For Medical Research Immunological advanced glycation endproduct crosslink
EP1354206A2 (de) * 2000-12-13 2003-10-22 Bio-Rad Laboratories, Inc. Standard-verdünnungsmittel für multiplex-bestimmungen

Also Published As

Publication number Publication date
ATE283481T1 (de) 2004-12-15
ES2231601T3 (es) 2005-05-16
US20030073138A1 (en) 2003-04-17
JP2002357608A (ja) 2002-12-13
DE60202008T2 (de) 2005-12-01
JP3646097B2 (ja) 2005-05-11

Similar Documents

Publication Publication Date Title
ATE283481T1 (de) Verfahren zum auffinden von reagenzien und festphasenkomponenten in spezifischen bindungsassays, frei von fortgeschrittenen glykosylierungsendprodukten
EP1379693A4 (de) Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes
DE60230927D1 (de) Fangverbindungen, ihre entnahme und verfahren zur analysierung des proteoms und von komplexen zusammensetzungen
DE50003766D1 (de) Verfahren und vorrichtung zum nachweis und zur quantifizierung von biomolekülen
ATE337855T1 (de) Verfahren und vorrichtung zur vorbehandlung von proben durch zentrifugieren
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DE60029957D1 (de) Verfahren und kit zum nachweis von betalactam enthaltenden verbindungen
CY1109597T1 (el) Διαδικασια για την επιλογη υψηλης ομοιομορφιας σε ενα στοχο συνδετικων νουκλεϊνικων οξεων με δισδιαστατο διαχωρισμο
ATE314385T1 (de) Verfahren zur gewinnung von nukleinsäuren mit hilfe chaotroper-und ammoniumreagentien
WO2004057336A3 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
ATE221657T1 (de) Entstörung durch rheumafaktoren
DE60122411D1 (de) Verfahren und Vorrichtung zur Konzentrationsbestimmung von einer Lösung, und Vorrichtung zur Verdünnung und Vorbereitung von Reagenzen
WO2001051669A3 (en) Nucleic acid binding assay and selection method
WO2004001420A8 (de) Verfahren und reagenz zur spezifischen identifizierung und quantifizierung von einem oder mehreren proteinen in einer probe
ATE319735T1 (de) Aufreinigung von substanzen aus einer biologischen probe
DE59606129D1 (de) Verfahren und verbindungen zur detektion von analyten mittels remanenzmessung und deren verwendung
ATE408710T1 (de) Nachweis von legionella durch ein pcr und fret verwendendes verfahren
ATE336590T1 (de) Verfahren zum thermodynamischen hochdurchsatzscreening von liganden
ATA3372001A (de) Verfahren zur detektion von nukleinsäuremolekülen
FI885312L (fi) Menetelmä spesifisesti sitovan proteiinin ja vastaavan sidottavan aineen välisen reaktion yhden tai useamman komponentin määrittämiseksi koenäytteestä käyttäen ainakin yhtä leimattua komponenttia, menetelmä leimatun komponentin valmistamiseksi sekä koepakkaus.......
ATE489635T1 (de) Vorrichtung, verfahren und verwendung zur behandlung von proben
DE602004014098D1 (de) Verfahren und System zur Qualitätüberwachung von industriellen Prozessen
DE60336261D1 (de) Verfahren zur herstellung von werkzeugen für analysen
DE60219429D1 (de) Biochemisches verfahren und vorrichtung zur bestimmung von eigenschaften von proteinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee